loadpatents
name:-0.025553941726685
name:-0.013069868087769
name:-0.0037121772766113
Greenman; Kevin Lloyd Patent Filings

Greenman; Kevin Lloyd

Patent Applications and Registrations

Patent applications and USPTO patent grants for Greenman; Kevin Lloyd.The latest application filed is for "c5ar antagonists".

Company Profile
3.13.23
  • Greenman; Kevin Lloyd - Sunnyvale CA
  • Greenman; Kevin Lloyd - Burlingame CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
C5ar Antagonists
App 20210269398 - Fan; Pingchen ;   et al.
2021-09-02
C5aR antagonists
Grant 10,660,897 - Fan , et al.
2020-05-26
C5aR ANTAGONISTS
App 20190060321 - FAN; Pingchen ;   et al.
2019-02-28
C5aR ANTAGONISTS
App 20190062275 - FAN; Pingchen ;   et al.
2019-02-28
Azaindazole Compounds And Methods Of Use
App 20180250293 - ZHANG; Penglie ;   et al.
2018-09-06
C5aR antagonists
Grant 10,035,768 - Fan , et al. July 31, 2
2018-07-31
C5ar Antagonists
App 20180179160 - FAN; Pingchen ;   et al.
2018-06-28
C5ar Antagonists
App 20170114017 - FAN; Pingchen ;   et al.
2017-04-27
C5aR ANTAGONISTS
App 20170065604 - FAN; Pingchen ;   et al.
2017-03-09
C5AR antagonists
Grant 9,573,897 - Fan , et al. February 21, 2
2017-02-21
Azaindazole Compounds And Methods Of Use
App 20160296517 - ZHANG; Penglie ;   et al.
2016-10-13
C5ar Antagonists
App 20160229802 - FAN; Pingchen ;   et al.
2016-08-11
Azaindazole compounds and methods of use
Grant 9,296,740 - Zhang , et al. March 29, 2
2016-03-29
C5AR antagonists
Grant 9,126,939 - Fan , et al. September 8, 2
2015-09-08
C5aR ANTAGONISTS
App 20150141425 - Fan; Pingchen ;   et al.
2015-05-21
C5aR antagonists
Grant 8,906,938 - Fan , et al. December 9, 2
2014-12-09
Azaindazole Compounds And Methods Of Use
App 20130338157 - Zhang; Penglie ;   et al.
2013-12-19
C5aR ANTAGONISTS
App 20130317028 - Fan; Pingchen ;   et al.
2013-11-28
C5ar Antagonists
App 20130172347 - Fan; Pingchen ;   et al.
2013-07-04
C5aR antagonists
Grant 8,445,515 - Fan , et al. May 21, 2
2013-05-21
C5aR ANTAGONISTS
App 20110275639 - Fan; Pingchen ;   et al.
2011-11-10
Azaindazole Compounds And Methods Of Use
App 20110098308 - Zhang; Penglie ;   et al.
2011-04-28
C5aR ANTAGONISTS
App 20100311753 - Fan; Pingchen ;   et al.
2010-12-09
Monocyclic and bicyclic compounds and methods of use
Grant 7,790,726 - Zhang , et al. September 7, 2
2010-09-07
Azaindazole compounds and methods of use
Grant 7,777,035 - Zhang , et al. August 17, 2
2010-08-17
C5aR ANTAGONISTS
App 20100160320 - Fan; Pingchen ;   et al.
2010-06-24
Piperidine derivatives and methods of use
Grant 7,576,106 - Zhang , et al. August 18, 2
2009-08-18
4-phenylpiperdine-pyrazole CCR1 antagonists
Grant 7,576,218 - Zhang , et al. August 18, 2
2009-08-18
Azaindazole Compounds And Methods Of Use
App 20080058341 - Zhang; Penglie ;   et al.
2008-03-06
Piperidine derivatives and methods of use
App 20070093467 - Zhang; Penglie ;   et al.
2007-04-26
Piperidine derivatives and methods of use
App 20070088036 - Zhang; Penglie ;   et al.
2007-04-19
Monocyclic and bicyclic compounds and methods of use
App 20070066583 - Zhang; Penglie ;   et al.
2007-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed